CLINICAL_TRIALS
trial_result
· 2024-01-12
Clinical Trial Update: Pharmacokinetics and Safety of SAR441236 [Phase 1]
Summary
Phase 1 pharmacokinetics and safety update for SAR441236 in HIV-1 infection; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV-1-infection | Phase 1 | Status: TERMINATED | Results posted: 2024-01-12